Everolimus Sandoz 0,25 mg Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

everolimus sandoz 0,25 mg

sandoz pharmaceuticals d.d., slovinsko - everolimus - 59 - immunopraeparata

Kyselina mykofenolová Sandoz 360 mg gastrorezistentné tablety Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

kyselina mykofenolová sandoz 360 mg gastrorezistentné tablety

sandoz pharmaceuticals d.d., slovinsko - kyselina mykofenolová - 59 - immunopraeparata

Kyselina mykofenolová Sandoz 180 mg gastrorezistentné tablety Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

kyselina mykofenolová sandoz 180 mg gastrorezistentné tablety

sandoz pharmaceuticals d.d., slovinsko - kyselina mykofenolová - 59 - immunopraeparata

Sandimmun Neoral 100 mg Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandimmun neoral 100 mg

novartis slovakia s.r.o., slovensko - cyklosporín - 59 - immunopraeparata

Sandimmun Neoral 50 mg Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandimmun neoral 50 mg

novartis slovakia s.r.o., slovensko - cyklosporín - 59 - immunopraeparata

Jemperli Unió Europea - eslovac - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Thiotepa Riemser Unió Europea - eslovac - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastické činidlá - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Xembify 200 mg/ml roztok na subkutánnu injekciu Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

xembify 200 mg/ml roztok na subkutánnu injekciu

instituto grifols, s.a., Španielsko - normálne ľudské imunoglobulíny na extravenózne použitie - 59 - immunopraeparata

Opdualag Unió Europea - eslovac - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanóm - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Thiotepa Fresenius Kabi 100 mg Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

thiotepa fresenius kabi 100 mg

fresenius kabi s.r.o., Česká republika - tiotepa - 44 - cytostatica